American Century Companies Inc Vericel Corp Transaction History

American Century Companies Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$29.0 - $38.37 $192,763 - $255,045	6,647 New	6,647 $249,000
Q2 2022 Aug 12, 2022	SELL	$22.88 - $39.45 $3,432 - $5,917	-150 Reduced 1.5%	9,832 $248,000
Q2 2021 Aug 05, 2021	SELL	$47.2 - $67.81 $397,754 - $571,434	-8,427 Reduced 45.78%	9,982 $524,000
Q1 2021 May 14, 2021	BUY	$30.93 - $59.48 $302,062 - $580,881	9,766 Added 112.99%	18,409 $1.02 Million
Q4 2020 Feb 12, 2021	BUY	$18.53 - $31.5 $160,154 - $272,254	8,643 New	8,643 $267,000
Q2 2020 Aug 13, 2020	SELL	$8.5 - $15.82 $571,829 - $1.06 Million	-67,274 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$7.25 - $19.22 $3,574 - $9,475	-493 Reduced 0.73%	67,274 $617,000
Q4 2019 Feb 12, 2020	SELL	$13.77 - $19.2 $1.37 Million - $1.91 Million	-99,291 Reduced 59.44%	67,767 $1.18 Million
Q3 2019 Nov 13, 2019	BUY	$14.93 - $19.83 $2.49 Million - $3.31 Million	167,058 New	167,058 $2.53 Million
Q2 2019 Aug 14, 2019	SELL	$15.01 - $18.89 $2.36 Million - $2.98 Million	-157,547 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$16.23 - $20.29 $434,753 - $543,508	26,787 Added 20.49%	157,547 $0
Q4 2018 Feb 13, 2019	BUY	$10.77 - $18.44 $1.41 Million - $2.41 Million	130,760 New	130,760 $2.28 Million

277

48.3M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.78B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.